Clinical Trial: Long-Term Treatment of Collagenous Colitis With Budesonide

Study Status: Terminated
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Long-Term Treatment of Collagenous Colitis With Budesonide. Prospective, Doubleblind Placebo-Controlled Trial.

Brief Summary: The aim of the trial is to examine the effect of budesonide treatment on collagenous colitis. All patients is treated for 6 weeks with budesonide and thereafter randomised to 24 weeks treatment with placebo or continued budesonide. The end poit is effect on clinical symptoms (number of daily stools)

Detailed Summary:
Sponsor: Bonderup, Ole K., M.D.

Current Primary Outcome: Clinical symptoms

Original Primary Outcome: Same as current

Current Secondary Outcome: Histological changes

Original Secondary Outcome: Same as current

Information By: Bonderup, Ole K., M.D.

Dates:
Date Received: August 29, 2005
Date Started: September 2004
Date Completion: March 2006
Last Updated: March 3, 2008
Last Verified: August 2005